EDC VENDOR QUALIFICATION SERVICES
BioBoston CRO provides Electronic Data Capture vendor qualification services for sponsors that need to assess whether an EDC provider, platform, service team, validation package, security model, and operating controls are fit for the intended clinical study use. Support can include request-for-information criteria, risk based qualification, quality-system review, validation assessment, security and data-integrity review, vendor audit interfaces, selection support, or requalification after material change.
Global Reach
Therapeutic Area Coverage
Years of Experience
START A CONVERSATION
Select the support you need and share a few details about your project. We’ll use this information to route your inquiry to the appropriate BioBoston team member.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
The engagement should be scoped around the current state of the work, the intended decision or milestone, the source package, and the sponsor's approval responsibilities.
Translate protocol, data, security, validation, support, integration, and business needs into qualification and selection criteria before commercial commitment.
Assess whether the vendor's lifecycle, requirements, testing, release, change, incident, backup, recovery, access, audit trail, and documentation are adequate for sponsor reliance.
Evaluate material platform, hosting, organization, subcontractor, security, validation, service, or regulatory changes and determine required follow-up.
when needed
Problems
The service is most valuable when the team can identify the specific control gap, decision, deliverable, or
recovery need rather than requesting generic capacity.
Scope
The exact scope depends on the maturity of the work, the quality of the inputs, the sponsor’s procedures,
the review model, and the target milestone.
Deliverables
Deliverables should be confirmed at kickoff and linked to defined sponsor decisions, review cycles, and downstream handoffs.
Client inputs
The sponsor does not need every detail finalized before kickoff, but approved decisions, open questions, source owners, reviewers, and deadlines must be distinguishable.
Process
1. Confirm the purpose, current state, intended use, milestone, stakeholders, responsibilities, systems or vendors, and agreed deliverables.
2. Review available source materials, prior decisions, procedures, evidence, and open issues; issue a focused gap and dependency list.
3. Develop the work plan, specifications, document, assessment, or control package included in scope.
4. Coordinate review through named sponsor and cross-functional decision owners and maintain a controlled open-item and comment process.
5. Perform the agreed technical, quality, consistency, or operational checks and document remaining risks or limitations.
6. Prepare the approved handoff, implementation, submission, remediation, archive, or next-step package as defined in scope.
Considerations
The work should remain proportionate to the risk and intended use, follow the sponsor’s controlled process, and preserve clear sponsor decision authority.
Engagement options
BioBoston leads the defined scope from assessment and planning through drafting or execution, review, quality control, and handoff.
BioBoston addresses a specific section, decision, backlog, finding, vendor issue, or stalled deliverable without expanding the engagement unnecessarily.
BioBoston provides an objective second-line review, oversight role, or embedded specialist while the sponsor or another vendor retains primary execution.
RELATED SERVICES
Configure and validate the study-specific database after platform and vendor suitability are established.
Design the forms and data-capture structure that the selected EDC must support.
Define the study data-management responsibilities, controls, data flow, cleaning, reconciliation, lock, and archive model.
Manage ongoing service performance, deliverables, metrics, meetings, incidents, issues, and escalation after selection.
Expertise
EDC qualification experience should match the intended use, platform model, validation approach, hosting, security, data-integrity controls, integrations, regions, study risk, and sponsor reliance strategy.
RESOURCES
Explore the following resources for additional insights and information relevant to this service.
A planned checklist for intended use, quality system, lifecycle, validation, security, data integrity, support, continuity, subcontractors, and exit. .
A planned comparison tool for functional, technical, quality, security, service, commercial, implementation, and risk criteria.
A planned framework for lifecycle evidence, requirements, testing, traceability, deviations, release, changes, limitations, and sponsor responsibilities.
FAQs
Qualification may assess intended use, quality system, software lifecycle, validation, security, data
integrity, hosting, privacy, backup, recovery, continuity, integrations, implementation, support, service levels, subcontractors, and exit controls.
No. Vendor qualification assesses the provider and platform. The configured study database still requires requirements, build, review, testing, approval, release, and change controls appropriate to intended use.
Yes. A structured comparison can use approved functional, technical, quality, validation, security, service, implementation, business, and risk criteria rather than relying only on demonstrations and price.
Yes, when documentation, interviews, demonstrations, system evidence, confidentiality controls, and
sampling objectives can be achieved remotely. Onsite or deeper audit work may be recommended for higher risk.
Requalification may be triggered by material platform, hosting, ownership, subcontractor, quality-system, security, validation, service, incident, performance, regulatory, or intended-use changes.
No. It supports a documented selection and risk decision. The sponsor must still validate intended use, oversee the vendor, manage configuration and changes, and monitor performance.
PROJECT FORM
Share the study, intended use, candidate vendor or platform, selection stage, integrations, validation and security expectations, target decision date, and principal concerns. A BioBoston team member will review the request and follow up regarding fit and possible next steps.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
A productive first discussion identifies intended use, study risk, candidates, integrations, validation reliance, security, support, timeline, and decision criteria. BioBoston can then define the qualification, comparison, audit, or requalification scope.
